X PARSOLEX PARTNER SOLUTIONS EXCELLENCE
LIVE

Serial Number

88570495

Owner

Parsolex GMP Center, Inc.

Attorney

Jill J. Chalmers

First Use Date

Oct 28, 2019

Filing Date

Aug 7, 2019

Add to watchlist:

No watchlists yet
View on USPTO

X PARSOLEX PARTNER SOLUTIONS EXCELLENCE Trademark

Serial Number: 88570495 • Registration: 6356728

X PARSOLEX PARTNER SOLUTIONS EXCELLENCE is a trademark filed by Parsolex GMP Center, Inc. on August 7, 2019. The trademark is classified under Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Parsolex GMP Center, Inc. (9 trademarks)

West Lafayette, IN 47906

Entity Type: 03

Trademark Details

Filing Date

August 7, 2019

Registration Date

May 18, 2021

First Use Anywhere

October 28, 2019

First Use in Commerce

October 28, 2019

Published for Opposition

July 28, 2020

Goods & Services

Consulting services in the field of regulatory compliance in the pharmaceutical, medical and healthcare industries; regulatory services for others, namely, tracking and monitoring regulatory requirements in the field of the pharmaceutical, medical, and healthcare industries for regulatory compliance purposes

Market assessment services; consulting services, namely, providing market research and business analysis services in the pharmaceutical, medical and healthcare fields; business consulting and planning services in the field of pharmaceuticals, medicine and healthcare; business consulting and planning services in the field of the commercialization of pharmaceuticals, medicines and healthcare products; business consulting services relating to product distribution, operations management services, logistics, reverse logistics, supply chain, and production systems and distribution solutions; consulting in the fields of sales methods, sales management, and sales improvement; business consultation; business administration consultation services; business operation consultation services; business consulting services in the field of pharmaceutical manufacturing, pharmaceutical packaging, and distribution; business consulting in the pharmaceutical products, medical and healthcare industries; business consulting, business management, business advisory services; marketing consulting services in the field of pharmaceuticals, medicine and healthcare; business marketing consulting services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; branding and marketing services for others in the field of pharmaceutical, medical, and healthcare industries; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; advertising of custom services for pharmaceutical formulation design, design of processes to transform inorganic and organic substances, scale-up of pharmaceutical manufacturing processes, pharmaceutical technology transfer, manufacture of pharmaceuticals, and chemical and physical evaluation of pharmaceuticals for others; distributorship services of pharmaceutical and medical products for others; commercialization of pharmaceuticals and medical products for others

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 18, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
May 18, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 16, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 15, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 2, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 1, 2021 AITU
USE AMENDMENT FILED
Mar 17, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 17, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 22, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 28, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 28, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 8, 2020 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 24, 2020 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 16, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 16, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 16, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 16, 2020 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 10, 2020 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 5, 2020 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 22, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 22, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 22, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 22, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 16, 2020 CRFA
ASSIGNED TO LIE
Apr 15, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2020 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Oct 31, 2019 GPRN
PRIORITY ACTION E-MAILED
Oct 31, 2019 GPRA
PRIORITY ACTION WRITTEN
Oct 31, 2019 CPRA
ASSIGNED TO EXAMINER
Oct 16, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 27, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 24, 2019 NWOS
NEW APPLICATION ENTERED
Aug 10, 2019 NWAP